Hepatic impairment Administration of tapentadol resulted in better exposures and serum stages to tapentadol in topics with impaired hepatic purpose in comparison to subjects with regular hepatic perform. The ratio of tapentadol pharmacokinetic parameters to the moderate and reasonable hepatic impairment groups in comparison to the traditional hepat